Tuesday, August 4, 2015   

China to put Glaxo investigators on trial
(07-29 16:28)

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.
The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial.'' Authorities had told U.S. and British diplomats they would be barred because the trial involved secret information but later reversed that decision.
Yu and Humphrey were detained last year and accused of improperly obtaining information such as home addresses of Chinese citizens for reports sold to corporate clients.
Yu and Humphrey worked for Glaxo, which faces an investigation into allegations it bribed doctors to use its medicines. Authorities have given no indication whether the two cases are connected. --AP   
Other China breaking news:
Xi’an floods kill nine visitors (2 mins ago)
China urges transparency in Pacific trade deal (8 mins ago)
National volleyball chief faces corruption inquiry (1 hr 39 mins ago)
Beijing keeps marine disputes off ASEAN agenda (2 hrs 51 mins ago)
Super typhoon Soudelor headed for China (08-04 12:16)
Military chief tells PLA to draw lessons from history (08-03 19:36)
Infant survives Beijing toilet birth (08-03 19:07)
Capital opens first private mental health clinic (08-03 18:03)
Beijing fraudsters held for government jobs scam (08-03 18:00)
Provincial officials investigated for corruption (08-03 17:54)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.